MedTrace Logo

Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)

NCT07164742 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 690

Last updated 2026-03-27

No results posted yet for this study

Summary

Individual-level, unblinded randomized controlled trial of an 8-week (short arm) or 24-week (extended arm) pulmonary rehabilitation program, relative to standard of care, to prevent post-tuberculosis respiratory morbidity. Randomization will occur in a 1:1:1 ratio at the initiation of treatment.

Conditions

  • TB - Tuberculosis
  • TB
  • TB Infection

Interventions

BEHAVIORAL

8 week (short arm) Intervention - pulmonary rehabilitation

8 weeks (short arm) of a pulmonary rehabilitation (PR) program, administered during TB treatment, comprising of exercise training, counselling and education, and airway clearance techniques.

BEHAVIORAL

24 week (long arm) Intervention - pulmonary rehabilitation

24 weeks (extended arm) of a pulmonary rehabilitation (PR) program, administered during TB treatment, comprising of exercise training, counselling and education, and airway clearance techniques.

Sponsors & Collaborators

Principal Investigators

  • Akshay Gupte, PhD MBBS MSPH · Boston University

  • Jonathan Golub, PhD MPH · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-18
Primary Completion
2028-09-15
Completion
2028-09-15

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07164742 on ClinicalTrials.gov